• Citer

Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial

par Twelves, Chris;Yardley, Denise;Potter, David D.A.;Mailliez, Audrey;Moreno-Aspitia, Alvaro;Ahn, Jin Seok;Zhao, Carol;Hoch, Ute;Tagliaferri, Mary;Hannah, Alison L;Rugo, Hope;Cortes, Javier;O'Shaughnessy, Joyce;Awada, Ahmad ;Perez, Edith A;Im, Seock Ah;Gómez-Pardo, Patricia;Schwartzberg, Lee L.S.;Diéras, Véronique
Référence European journal of cancer, 76, page (205-215)
Publication Publié, 2017-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial
Auteur:	Twelves, Chris; Yardley, Denise; Potter, David D.A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L; Rugo, Hope; Cortes, Javier; O'Shaughnessy, Joyce; Awada, Ahmad; Perez, Edith A; Im, Seock Ah; Gómez-Pardo, Patricia; Schwartzberg, Lee L.S.; Diéras, Véronique
Informations sur la publication:	European journal of cancer, 76, page (205-215)
Statut de publication:	Publié, 2017-05
Sujet CREF:	Cancérologie
Mots-clés:	Advanced breast cancer
	Etirinotecan pegol
	Metastatic breast cancer
	NKTR-102
	Quality of life
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2017.02.011
	info:pii/S0959804917307360
	info:scp/85016140559